2m 2m 2m 2m 2m 2m 2m
CAPRICOR THERAP (CAPR)
NASDAQ
$20.42-$0.20 (-0.95%)
Price as of Jul 14, 2026 6:44 AM EDT- $1.2BMarket Cap
- 179.08%1-Year Change
- BiotechnologyIndustry
CAPRICOR THERAP (CAPR)
$20.42-$0.20 (-0.95%)
CAPR | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $20.61 | ||
Change | -$0.90 (-4.18%) | ||
Open | $21.30 | ||
High | $21.53 | ||
Low | $20.17 | ||
Previous Close | $21.51 | ||
Volume | 1,275,764 | ||
30-Day Average Volume | 1,754,144 | ||
1-Week Change | -8.11% | ||
1-Month Change | -20.12% | ||
1-Year Change | 179.08% | ||
3-Year Change | 366.29% | ||
5-Year Change | 349.02% | ||
Fundamentals | |||
Shares Outstanding | 57.9M | ||
Total Assets | $326.3M | ||
Market Cap | $1.2B | ||
Enterprise Value | $1.1B | ||
Period: QTR TTM FY | |||
Revenue | $0.00 | ||
Net Income | -$33.9M | ||
Free Cash Flow | -$34.4M | ||
EBIT | -$33.9M | ||
EBITDA | -$33.4M | ||
Net Working Capital | $249.5M | ||
EPS | -$0.59 | ||
Enterprise Value/EBITDA | -33 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 4 | ||
P/E | -35 | ||
PEG | -8 | ||
Price/Free Cash Flow | -35 | ||
Price/Operating Cash Flow | -41 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 10 | ||
Last Split Date | 06/05/2019 | ||
Earnings & Revenue